Glenmark Pharmaceuticals Limited's total assets for Q4 2025 were ₹160.50B, an increase of Infinity% from the previous quarter. IN:GLENMARK total liabilities were ₹72.00B for the fiscal quarter, a -185.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.